Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys

Journal of Pharmaceutical Sciences

Volumn 100, Issue 9, 2011, Pages 3939-3950

  Ito, Katsuaki ^a   Uchida, Yasuo ^a   Ohtsuki, Sumio ^a   Aizawa, Sanshiro ^a   Kawakami, Hirotaka ^a   Katsukura, Yuki ^a   Kamiie, Junichi ^b   Terasaki, Tetsuya ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b AZABU UNIVERSITY   (Japan)

Author keywords

ABC transporters; Blood brain barrier; CNS; Mass spectrometry; Membrane transporter; P glycoprotein; Proteomics; Transporters

Indexed keywords

ABC TRANSPORTER A1; ADENOSINE TRIPHOSPHATASE; BREAST CANCER RESISTANCE PROTEIN; CLAUDIN 5; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE PROTEIN; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 3; MONOCARBOXYLATE TRANSPORTER 8; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; OCCLUDIN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; TAURINE TRANSPORTER; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; LIQUID CHROMATOGRAPHY; MALE; MICROVASCULATURE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY;

EID: 79953718797     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22487     Document Type: Article

References (43)

1. Syvänen S, Lindhe O, Palner M, Kornum BR, Rahman O, Långström B, Knudsen GM, Hammarlund-Udenaes M. 2009. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 37:635-643.
2. Matsuoka Y, Okazaki M, Kitamura Y, Taniguchi T. 1999. Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 39:383-392.
3. Ose A, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Fujita T, Yamamoto A, Sugiyama Y. 2008. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Drug Metab Dispos 36:427-434.
4. Daood M, Tsai C, Ahdab-Barmada M, Watchko JF. 2008. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 39:211-218.
5. Warren MS, Zerangue N, Woodford K, Roberts LM, Tate EH, Feng B, Li C, Feuerstein TJ, Gibbs J, Smith B, de Morais SM, Dower WJ, Koller KJ. 2009. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 59:404-413.
6. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Declèves X. 2008. ABC transporters, cytochromes P450 and their main transcription factors: Expression at the human blood-brain barrier. J Neurochem 107:1518-1528.
7. Yousif S, Saubaméa B, Cisternino S, Marie-Claire C, Dauchy S, Scherrmann JM, Declèves X. 2008. Effect of chronic exposure to morphine on the rat blood-brain barrier: Focus on the P-glycoprotein. J Neurochem 107:647-657.
8. Imai Y, Ishikawa E, Asada S, Sugimoto Y. 2005. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596-604.
9. Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y. 2006. Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci 97:1198-1204.
10. Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. 2008. Quantitative atlas of membrane transporter proteins: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res 25:1469-1483.
11. Beck MJ, Padgett EL, Bowman CJ, Wilson DT, Kaufman LE, Varsho BJ, Stump DG, Nemex MD, Hoson JF. 2006. Design consideration for nonclinical juvenile toxicity studies. In Developmental and reproductive toxicology: A practical approach; Hood RD, ed. New York: CRC Press, pp 274-280.
12. Kawakami H, Ohtsuki S, Kamiie J, Suzuki T, Abe T, Terasaki T. 2011. Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection. J Pharm Sci 100:341-352.
13. Oostendorp RL, Buckle T, Beijnen JH, van Tellingen O, Schellens JH. 2009. The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. Invest New Drugs 27:31-40.
14. Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y. 2010. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone. J Pharmacol Exp Ther 333:788-796.
15. Mori S, Ohtsuki S, Takanaga H, Kikkawa T, Kang YS, Terasaki T. 2004. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem 90:931-941.
16. Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S, Sugiyama Y. 2010. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Drug Metab Dispos 38:168-176.
17. Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, Terasaki T. 2003. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 23:432-440.
18. Irifune M, Fukuda T, Nomoto M, Sato T, Kamata Y, Nishikawa T, Mietani W, Yokoyama K, Sugiyama K, Kawahara M. 1997. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: Comparison with the effects during the recovery and subanesthetic phases. Brain Res 763:281-284.
19. Sharman DF. 1966. Changes in the metabolism of 3, 4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother 28:153-163.
20. Adolfsson R, Gottfries CG, Roos BE, Winblad B. 1979. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216-223.
21. Heuer H. 2007. The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 21:265-276.
22. Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota-Martinez C, Dumitrescu AM, Refetoff S, Morte B, Bernal J. 2009. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3, 5, 3'-triiodo-l-thyronine. Endocrinology 150:2491-2496.
23. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H. 2007. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117:627-635.
24. Tohyama K, Kusuhara H, Sugiyama Y. 2004. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145:4384-4391.
25. Kita YF, Hosomichi K, Kohara S, Itoh Y, Ogasawara K, Tsuchiya H, Torii R, Inoko H, Blancher A, Kulski JK, Shiina T. 2009. MHC class I A loci polymorphism and diversity in three Southeast Asian populations of cynomolgus macaque. Immunogenetics 61:635-648.
26. Zong J, Pollack GM. 2003. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. J Pharmacol Exp Ther 306:556-562.
27. Perloff MD, von Moltke LL, Fahey JM, Greenblatt DJ. 2007. Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells. J Pharm Pharmacol 59:947-953.
28. Perloff MD, von Moltke LL, Fahey JM, Daily JP, Greenblatt DJ. 2000. Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture. AIDS 14:1287-1289.
29. Vannucci SJ. 1994. Developmental expression of GLUT1 and GLUT3 glucose transporters in rat brain. J Neurochem 62:240-246.
30. Davison AN, Dobbing J. 1966. Myelination as a vulnerable period in brain development. Br Med Bull 22:40-44.
31. Thorens B, Mueckler M. 2010. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298:141-145.
32. Halestrap AP, Meredith D. 2004. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447:619-628.
33. Yeh YY, Streuli VL, Zee P. 1977. Ketone bodies serve as important precursors of brain lipids in the developing rat. Lipids 12:957-964.
34. Webber RJ, Edmond J. 1977. Utilization of l(+)-3-hydroxybutyrate, d(-)-3-hydroxybutyrate, acetoacetate, and glucose for respiration and lipid synthesis in the 18-day-old rat. J Biol Chem 252:5222-5226.
35. Leino RL, Gerhart DZ, Drewes LR. 1999. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: A quantitative electron microscopic immunogold study. Brain Res Dev Brain Res 113:47-54.
36. Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR. 2001. Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 38:519-527.
37. Wu X, Freeze HH. 2002. GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 80:553-557.
38. Mantych GJ, James DE, Chung HD, Devaskar SU. 1992. Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain. Endocrinology 131:1270-1278.
39. Ohtsuki S, Terasaki T. 2007. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 24:1745-1758.
40. Shuper A, Stark B, Kornreich L, Cohen IJ, Avrahami G, Yaniv I. 2002. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. Isr Med Assoc J 4:1050-1053.
41. Dejana E. 2004. Endothelial cell-cell junctions: Happy together. Nat Rev Mol Cell Biol 5:261-270.
42. Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M, Roncali L. 2004. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 122:51-59.
43. Ferguson RK, Woodbury DM. 1969. Penetration of 14C-inulin and 14C-sucrose into brain, cerebrospinal fluid, and skeletal muscle of developing rats. Exp Brain Res 7:181-194.